Mindfulness Based Stress Reduction and Post-Stroke Cognition
Mindfulness Matters: The Impact of Mindfulness Based Stress Reduction on Post-Stroke Cognition
1 other identifier
interventional
30
1 country
1
Brief Summary
The investigators don't fully understand how, regardless of the size or location in the brain, minor strokes can result in significant problems with focus, attention, and multi-tasking that prevent individuals from returning to an active lifestyle, and negatively impact quality of life; but the investigators' preliminary data using magnetoencephalography (MEG) suggest that there may be disruption of the neuronal network and abnormal frontal lobe activity in the brain after stroke. Mindfulness Based Stress Reduction (MBSR) is effective at treating frontal lobe dysfunction in the form of anxiety and depression occurring during the chronic phase of stroke recovery. The aim of this study is to use MBSR to improve other forms of frontal lobe dysfunction (cognitive outcomes) during the subacute phase of recovery, when patients are making critical decisions regarding patients' ability to return to work or live independently; and to use MEG, a tool capable of imaging brain activity and neuronal networks, to understand the brain changes that correspond to improvement after treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Jan 2021
Typical duration for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2020
CompletedFirst Posted
Study publicly available on registry
March 10, 2020
CompletedStudy Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedResults Posted
Study results publicly available
December 20, 2024
CompletedDecember 20, 2024
December 1, 2024
2.4 years
March 6, 2020
November 27, 2024
December 18, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Change in Cognition as Assessed by the Montreal Cognitive Assessment Score
The Montreal Cognitive Assessment (MoCA) tests executive function, attention, concentration, memory, and processing speed. The MoCA is scored on a scale of 0-30. Scores of less than 26 are considered abnormal.
Pre-intervention (1 month post-stroke) and post-intervention visit (6 months post-stroke)
Change in Cerebral Activity as Assessed by Functional Connectivity on Magnetoencephalography (MEG)
Participants will undergo an MEG evaluating functional connectivity during resting state. GC links within the ipsilesional FPC were determined and differences in link count is reported below.
Pre-intervention (1 month post-stroke) and post-intervention visit (6 months post-stroke)
Change in Quality of Life as Assessed by a Likert Scale
Patient-reported assessment of quality of life (Likert scale 1-7 with 7 being a better QOL) at the 1 and 6 month visits. Mean of participant choice is reported.
Pre-intervention (1 month post-stroke) and post-intervention visit (6 months post-stroke)
Change in Depression as Assessed by the Patient Health Questionnaire (PHQ-9)
The PHQ-9 will be administered to participants to evaluate for post-stroke depression. The PHQ-9 is scored on a scale of 0-27 with scores of 5-9 being indicative of mild depression and higher scores more severe depression.
Pre-intervention (1 months post-stroke) and post-intervention visit (6 months post-stroke)
Study Arms (2)
Mindfulness Based Stress Reduction (MBSR)
EXPERIMENTALParticipants randomized to the MBSR arm will undergo a standard 8 week course.
Stroke Support Group (SSG)
ACTIVE COMPARATORAs a control group, participants will participate in 8 weeks of weekly Stroke Support Group.
Interventions
Participants randomized to the MBSR arm will undergo a standard 8 week course of MBSR taught by a psychologist trained in the MBSR protocol and encouraged to engage in additional individual mindfulness sessions using a cell phone application.
As a control group, participants randomized to the SSG arm will participate in 8 weeks of weekly Stroke Support Group sessions to experience activity and socialization without additional mindfulness training.
Eligibility Criteria
You may qualify if:
- Adults (≥18 years) presenting with neurological symptoms due to acute ischemic stroke (symptom onset within the week prior to admission).
- Evidence on brain MRI of acute ischemic stroke (imaging negative strokes and transient ischemic attacks (TIAs) will be excluded).
- Native English speaker (by self-report) prior to stroke.
- NIHSS \<8 at initial follow-up visit (approximately 30 days post-stroke).
- mRS 0-2 at initial follow-up visit.
You may not qualify if:
- Primary intracerebral hemorrhage- as evidenced by blood on head CT or MRI.
- Presence of proximal large vessel occlusion.
- Cortical exam findings including aphasia or neglect.
- Prior history of dementia or undertreated psychiatric illness.
- Uncorrected hearing or visual loss.
- Inability to attend weekly MBSR or Stroke Support Group sessions.
- Inability to travel to College Park (UMD) for 2 MEG recording sessions.
- Presence of any of the following that would lead to significant artifact on MEG: cardiac pacemaker, intracranial clips, metal implants or external clips within 10mm of the head, metal implants in the eyes (unlikely given that all patients will have an MRI and criteria are similar).
- Claustrophobia, obesity, and/or any other reason leading to difficulty staying in the MEG machine for up to 1 hour.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Universitylead
- University of Maryland, College Parkcollaborator
- National Institutes of Health (NIH)collaborator
Study Sites (1)
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, 21224, United States
Related Publications (4)
Chen K, Marsh EB. Chronic post-stroke fatigue: It may no longer be about the stroke itself. Clin Neurol Neurosurg. 2018 Nov;174:192-197. doi: 10.1016/j.clineuro.2018.09.027. Epub 2018 Sep 17.
PMID: 30266010BACKGROUNDMarsh EB, Lawrence E, Hillis AE, Chen K, Gottesman RF, Llinas RH. Pre-stroke employment results in better patient-reported outcomes after minor stroke: Short title: Functional outcomes after minor stroke. Clin Neurol Neurosurg. 2018 Feb;165:38-42. doi: 10.1016/j.clineuro.2017.12.020. Epub 2017 Dec 27.
PMID: 29306185BACKGROUNDMarsh EB, Lawrence E, Gottesman RF, Llinas RH. The NIH Stroke Scale Has Limited Utility in Accurate Daily Monitoring of Neurologic Status. Neurohospitalist. 2016 Jul;6(3):97-101. doi: 10.1177/1941874415619964. Epub 2015 Dec 13.
PMID: 27366291BACKGROUNDGirgenti SG, Dallasta I, Lawrence E, Merbach D, Simon JZ, Llinas RH, Gould NF, Marsh EB. Modified-mindfulness-based stress reduction as a treatment for cognitive recovery in patients with minor stroke: a randomized controlled pilot study. Front Neurol. 2025 Aug 26;16:1534480. doi: 10.3389/fneur.2025.1534480. eCollection 2025.
PMID: 40933043RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
9 participants either did not complete the second MEG visit or had technical difficulties, resulting in only 21 pairs of pre- and post-MEG data available for analysis.
Results Point of Contact
- Title
- Elisabeth B. Marsh, MD
- Organization
- Johns Hopkins School of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Elisabeth B Marsh, MD
Johns Hopkins University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2020
First Posted
March 10, 2020
Study Start
January 1, 2021
Primary Completion
June 1, 2023
Study Completion
June 1, 2023
Last Updated
December 20, 2024
Results First Posted
December 20, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Results will be published at the conclusion of the study.
- Access Criteria
- Upon request
Individual participant data will be available upon request of the PI. Otherwise, de-identified results will be reported in aggregate.